Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Intercept reports fibrosis improvement in NASH trial

The trial is designed to enrol more than 2,000 adult NASH patients with stage II and III fibrosis. Credit: Nephron.



  • Intercept reports fibrosis improvement in NASH trial

Go Top